NIT
FLXN

NumerixS Investment Technologies’s Flexion Therapeutics, Inc. FLXN Stock Holding History

NumerixS Investment Technologies’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,218
Closed -$80K – 1374
2020
Q1 		$80K Buy
+10,218
New +$154K 0.04% 488
2019
Q3 		– Sell
-1,700
Closed -$21K – 1323
2019
Q2 		$21K Buy
+1,700
New +$19.6K 0.01% 908
2019
Q1 		– Sell
-5,000
Closed -$59K – 1413
2018
Q4 		$59K Sell
5,000
-5,289
-51% -$82.9K 0.02% 724
2018
Q3 		$196K Buy
10,289
+8,689
+543% +$200K 0.04% 592
2018
Q2 		$40K Buy
+1,600
New +$41.5K 0.01% 947
2018
Q1 		– Sell
-1,400
Closed -$35K – 1356
2017
Q4 		$35K Buy
+1,400
New +$34.3K 0.01% 922

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

NumerixS Investment Technologies's FLXN Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2020, closing a stake of 10,218 shares — an estimated $80K sold.

NumerixS Investment Technologies first reported a position in FLXN in Q4 2017 and held it in 6 quarters. The position peaked at $196K in Q3 2018. 125 funds tracked by Wall St. Rank hold FLXN as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Flexion Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 10,218 Flexion Therapeutics, Inc. shares in Q2 2020, an estimated $80K.
  • NumerixS Investment Technologies first reported a position in Flexion Therapeutics, Inc. in Q4 2017 and held it in 6 quarters.
  • NumerixS Investment Technologies's Flexion Therapeutics, Inc. position peaked at $196K in Q3 2018.
  • 125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.